A revised diagnostic algorithm provides guidelines for the diagnosis of patients with
suspected pulmonary hypertension, both prior to and following referral to expert centres, and …

Pulmonary arterial hypertension (PAH) is a rare, progressive disorder typified by occlusion
of the pulmonary arterioles owing to endothelial dysfunction and uncontrolled proliferation of …

Until 20 years ago the treatment of pulmonary arterial hypertension (PAH) was based on
case reports and small series, and was largely ineffectual. As a deeper understanding of the …

Rationale: Accumulating evidence implicates inflammation in pulmonary arterial
hypertension (PAH) and therapies targeting immunity are under investigation, although it …

Background There are limited data about the range of diseases, natural history, age-
appropriate endpoints and optimal care for children with pulmonary hypertension (PH) …

Abstract Background PVDOMICS (Pulmonary Vascular Disease Phenomics) is a precision
medicine initiative to characterize pulmonary vascular disease (PVD) using deep …

Pulmonary hypertension (PH) associated with left heart failure (LHF)(PH‐LHF) is one of the
most common causes of PH. It directly contributes to symptoms and reduced functional …

In recent years, the amnion (AM) has emerged as a versatile tool for stimulating tissue
regeneration and has been of immense interest for clinical applications. AM is an abundant …

Pulmonary arterial hypertension (PAH) is a deadly and uncurable disease characterized by
remodeling of the pulmonary vasculature and increased pulmonary artery pressure …

Background Subtypes of pulmonary arterial hypertension (PAH) differ in both fundamental
disease features and clinical outcomes. Angiogenesis and inflammation represent disease …